NuCana plc NCNA
0.75 USD +0.03 (+4.39%)
Regular-session close
0.72 -0.03 -3.66%
After hours · Nov 20, 4:00 PM ET
0.7026 Day range 0.7899
0.718 52-week range 4.43
- YTD
- -79.18%
- 1 year
- -78.95%
News
benzinga.com NuCana Presents New Preclinical Data Showing That NUC-7738 Enhanced Anti-Cancer Activity Of Carfilzomib Proteasome Inhibitor Used To Treat Patients With Multiple Myeloma NuCana plc (NASDAQ:NCNA) ("NuCana" or the "Company") today announced new preclinical data showing that NUC-7738 enhanced the anti-cancer activity of carfilzomib, an approved proteasome inhibitor used…
globenewswire.com NuCana Presents Preclinical Data Showing NUC-7738 Enhances Carfilzomib Activity in Multiple Myeloma Cell Lines at the 38th EORTC-NCI-AACR Symposium NUC-7738 Increased Proteasome Inhibition When Combined with Carfilzomib Data Presented Identify an Additional Potential Mode of Action for NUC-7738 and Support Evaluation of Additional Indications…
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session Gainers DataMEDS AI (NASDAQ:MEDS) shares increased by 48.4% to $1.08 during Friday's pre-market session. The company's market cap stands at $4.1 million. Akanda (NASDAQ:AKAN) stock increased by…
